TCL Archive New Seer Report Says Five Year Relative Survival At 49 Per Cent Over all, 50 Per Cent For White November 30, 1984
TCL Archive Genentech Move Nixes Hospital Discounts: Avastin, Herceptin, Rituxan Now Sold Under Tighter Control by Drug Maker October 3, 2014
TCL Archive In Brief: House, Senate Pass Rescision Bills; NCI Compromise Figure Probably About $10 Million Cut For FY 1981 May 29, 1981